$6.71
-0.07-1.03%
Last update: Nov 9, 5:23 PM
Achieve Life Sciences Inc
ACHVNASDAQ
The average analyst price target for Achieve Life Sciences is $14.90, 122.1% above the current price. Of 10 analysts, 10 rate it Buy. Targets range from $11 to $20. The latest change came on Sep 30, 2026, when Stifel initiated coverage of Achieve Life Sciences with a Buy rating and a $18 price target.
Price Target Range — 10 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
